Beximco Pharmaceuticals Limited R2WA.F Stock
Beximco Pharmaceuticals Limited Price Chart
Beximco Pharmaceuticals Limited R2WA.F Financial and Trading Overview
| Beximco Pharmaceuticals Limited stock price | 0.44 EUR |
| Previous Close | 0.38 EUR |
| Open | 0.38 EUR |
| Bid | 0.4 EUR x 3669800 |
| Ask | 0.44 EUR x 3183100 |
| Day's Range | 0.38 - 0.42 EUR |
| 52 Week Range | 0.37 - 1 EUR |
| Volume | 300 EUR |
| Avg. Volume | 663 EUR |
| Market Cap | 620.1M EUR |
| Beta (5Y Monthly) | 0.731849 |
| PE Ratio (TTM) | 5.25 |
| EPS (TTM) | 0.09 EUR |
| Forward Dividend & Yield | 0.03 (7.78%) |
| Ex-Dividend Date | November 17, 2022 |
| 1y Target Est | N/A |
R2WA.F Valuation Measures
| Enterprise Value | 165.95M EUR |
| Trailing P/E | 5.25 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Beximco Pharmaceuticals Limited Stock Price History
| Beta (5Y Monthly) | 0.731849 |
| 52-Week Change | -55.71% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1 EUR |
| 52 Week Low | 0.37 EUR |
| 50-Day Moving Average | 0.43 EUR |
| 200-Day Moving Average | 0.58 EUR |
R2WA.F Share Statistics
| Avg. Volume (3 month) | 663 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 446.11M |
| Float | 297.32M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 1.70% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | 317.00% |
| Payout Ratio | 0.3425 |
| Last Split Factor | 1.1:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 11.79% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 43.58% |
| EBITDA Margin | 21.92% |
Management Effectiveness
| Return on Assets (ttm) | 6.05% |
| Return on Equity (ttm) | 9.64% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | 6.60% |
| Gross Profit (ttm) | 15.71B EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 0.08 |
| Quarterly Earnings Growth (yoy) | -13.80% |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 24.43 EUR |
| Current Ratio (mrq) | 1.575 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Beximco Pharmaceuticals Limited
| Country | Germany |
| State | N/A |
| City | Dhaka |
| Address | 19 Dhanmondi R/A |
| ZIP | 1205 |
| Phone | 880 2 5861 1001 |
| Website | https://www.beximcopharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 5500 |
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
Q&A For Beximco Pharmaceuticals Limited Stock
What is a current R2WA.F stock price?
Beximco Pharmaceuticals Limited R2WA.F stock price today per share is 0.44 EUR.
How to purchase Beximco Pharmaceuticals Limited stock?
You can buy R2WA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Beximco Pharmaceuticals Limited?
The stock symbol or ticker of Beximco Pharmaceuticals Limited is R2WA.F.
Which industry does the Beximco Pharmaceuticals Limited company belong to?
The Beximco Pharmaceuticals Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Beximco Pharmaceuticals Limited have in circulation?
The max supply of Beximco Pharmaceuticals Limited shares is 880M.
What is Beximco Pharmaceuticals Limited Price to Earnings Ratio (PE Ratio)?
Beximco Pharmaceuticals Limited PE Ratio is 4.93333340 now.
What was Beximco Pharmaceuticals Limited earnings per share over the trailing 12 months (TTM)?
Beximco Pharmaceuticals Limited EPS is 0.09 EUR over the trailing 12 months.
Which sector does the Beximco Pharmaceuticals Limited company belong to?
The Beximco Pharmaceuticals Limited sector is Healthcare.